The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Items 801–847 of 847
Therapeutic potential of metformin-based combination therapy in acute myeloid leukemia
Shamahmood, M. N., Miri, A., Yousefi, M. J., & Mezginejad, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-04205-4
Molecular approach to cytopenia and bone marrow failure
Jain, J., & Borate, U. (2025) · Hematology · doi:10.1182/hematology.2025000724
Uddin, M. M., Zhou, Y., Bick, A. G., Burugula, B. B., Jaiswal, S., Desai, P., Honigberg, M. C., Love, S.-A., Barac, A., Hayden, K. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862531
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Figshare · doi:10.6084/m9.figshare.26982044
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Figshare · doi:10.6084/m9.figshare.26982038
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. N. (2023) · Figshare · doi:10.6084/m9.figshare.24225240
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Figshare · doi:10.6084/m9.figshare.26982035
Smith, C., Burugula, B. B., Jones, M. A., Li, Q., Kitzman, J. O., & Wong, T. N. (2024) · Figshare · doi:10.6084/m9.figshare.24225247
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Figshare · doi:10.6084/m9.figshare.26982047
Zhou, Y., Huang, G., Cai, X., Liu, Y., Qian, B., & Li, D. (2024) · Figshare · doi:10.6084/m9.figshare.26982041
Craig, J. M., Tobin, R. M., Wolfsberger, W., Oleksyk, T. K., Miura, S., Gerhard, G. S., & Kumar, S. (2025) · Journal of Molecular Evolution · doi:10.1007/s00239-025-10296-y
Genetic resistance to leukemia
Caiado, F., & Manz, M. G. (2026) · Science · doi:10.1126/science.aed5244
Mutant ASXL1 Drives Transcriptional Activation and Repression in Human HematopoiesisPreprint
Hall, M. L., Quintal, A., Worme, S. J., Nguyen, T., Schonrock, Z., Tsuchiya, M., Acharya, S. N., Carlson, H. L., Pacentine, I. V., Shrestha, S. B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.13.699315
Lan, Y., Zhao, Y., Sun, J., Zhou, D., Wang, J. H., Zheng, X., Shi, Y., Meng, H., Wei, J., Yang, C., et al. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06835-2
The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential
He, H., & Wang, J. (2026) · Aging and Cancer · doi:10.1002/aac2.70016
Harraka, P. A., Yeh, P. S.-H., Nicholls, S. J., & Southey, M. C. (2026) · Genetics in Medicine · doi:10.1016/j.gim.2026.102530
Lee, N. C. J., Miao, R., & Young, N. S. (2026) · Leukemia · doi:10.1038/s41375-026-02865-x
Tobin, J., Stelmach, P., Richter, S., Xu, D., Sauer, S., Raab, M. S., Gu, M., Dunn, W. G., Fabre, M. A., Müller‐Tidow, C., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025018279
Brisou, G. (2020) · theses.fr (ABES) · doi:10.70675/0b7366f2z1264z4d83z8f28z435932a47a1a
Courtier, F. (2019) · theses.fr (ABES) · doi:10.70675/3b5503f7z08fez4cefzbf99z98cbb1674794
Etude in vivo de la chimiorésistance dans les leucémies aigues myéloïdes humaines
Aroua, N. (2018) · theses.fr (ABES) · doi:10.70675/87716ea3z1f4dz4a62zb041z59f2afc4c3e9
Grenier, J. M. P. (2021) · theses.fr (ABES) · doi:10.70675/1aab1369zd34cz4476z8c46z39a2c3df85b6
Counting the CHIPs: The High-Stakes Role of Clonal Hematopoiesis in Multiple Myeloma
Szalay, M., Strange, I. S., Banwell, K., Campana, S., Dass, A., Hej-Ali, S., Mohamed, H., & Khan, S. (2026) · Biomedicines · doi:10.3390/biomedicines14040899
Tumor-Infiltrating Clonal Hematopoiesis and Pan-Cancer Prognosis in Patients With Solid Tumors
Yun, D., Chen, C., Qin, N., Wang, Z., & Song, N. (2026) · JAMA Oncology · doi:10.1001/jamaoncol.2026.1036
Asiri, A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1818483
Grubor, N. N., Gazibara, T. M., Cvjetković, S., Gregorić, P., Loncar, Z. M., Micić, D., Vasiljev, K. D., Ivančević, N., Milovanović, S., Pavić, N., et al. (2026) · Psychology Health & Medicine · doi:10.1080/13548506.2026.2680338
Chen, J., Wu, X.-Y., Li, X., Shi, Q., Fu, D., Kao, Y.-R., Zhu, Y., Wang, B.-E., Bian, H.-X., Zhao, Y., et al. (2026) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-25-0191
Epigenetic alterations in Myeloid Malignancies
Cardoso, B. A. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_12
Ravi, P. K., Zhong, C., Perez, K. J., Xie, W., Volpe, V. O., Lee, G.-S. M., Boardman, J., Pittard, E. G., Stoltenberg, H., Jacene, H. A., et al. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.126.272125
The blood remembers: HSC-iM and the cancer continuum
Coelho‐Silva, J. L., Pereira‐Martins, D. A., & Machado‐Neto, J. A. (2026) · Blood Cancer Journal · doi:10.1038/s41408-026-01581-0
Mosaic chromosomal alterations are suppressed in older adults with HIV
Behrouzfar, K., Han, W. M., Perera, R., Li, J., Scull, K. E., Howlett, K., Bloch, M., Baker, D. A., Eu, B., Bowden-Reid, E., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10532-1
Clonal hematopoiesis related to ionizing radiation in atomic bomb survivors
Taguchi, M., Sato, S., Nannya, Y., Mishima, H., Horai, M., Ando, K., Kinoshita, A., Saiki, R., Ochi, Y., Nagai, K., et al. (2026) · Leukemia · doi:10.1038/s41375-026-03101-2
Tang, B., Kuai, Y., Ye, Z., Zhao, X., Fan, C., Huang, M., Luo, Y., & Li, C. (2026) · Cell investigation. · doi:10.1016/j.clnves.2026.100088 · Cited by 1
Rampal, R. K., Winneker, R., Kuykendall, A., Michaelis, L. C., Abu-Zeinah, G. F., Koschmieder, S., Bewersdorf, J. P., Ng, Z. Y., Hobbs, G. S., Marcellino, B. K., et al. (2026) · Leukemia · doi:10.1038/s41375-026-03103-0
Yao, C., Chen, Y., Tsai, B.-R., Chen, J.-W., Chan, C., Chen, W., Lin, L.-Y., Chou, W., Ho, Y., & Yang, L. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.08.052
Ding, J., Jiang, Y., Xu, Z., Zheng, Y., & Pan, L. (2026) · Cell investigation. · doi:10.1016/j.clnves.2026.100092
Sadeghian, Z., Chen, J., Lyapichev, K. A., Fu, C., Chaulagain, C. P., Diacovo, M. J., Bosler, D. S., & Behdad, A. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70320
ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?
Liga, M., Georgopoulou, A. N., Tsokanas, D., Spyridonidis, A., & Labropoulou, V. T. (2026) · Cancers · doi:10.3390/cancers18182993
Nandi, R., Zhao, K., Pershad, Y., Nabi, K. N., Vlasschaert, C., Uddin, M. M., Natarajan, P., DeAngelo, D. J., Luskin, M. R., Lindsley, R. C., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104238
Somatic Blood Mosaicism and Psychiatric Disease: Current Evidence and Causal Limits
Belbe, A.-A., Pîrlog, L.-M., Pilatec, A.-N., Militaru, M.-S., Iordănescu, I. I., & Cătană, A. (2026) · Genes · doi:10.3390/genes17101224
Clonal hematopoiesis and biological aging: an interaction that increases cancer risk?
Tobin, J., & Vassiliou, G. S. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag309
Inflammation as a central driver in AML pathogenesis and therapy resistance
Luo, H., Ding, Y., Fan, S., Huang, X., & Zhao, X. (2026) · Science China Life Sciences · doi:10.1007/s11427-026-3436-8
Xia, C., Tang, Z., Zhang, S., Cushman‐Vokoun, A. M., Gundabolu, K., Haddadin, M., & Khoury, J. D. (2026) · Genes · doi:10.3390/genes17101255
Yu, X., Liu, Z., Jin, Y., Chen, Y., Li, P., Fan, Y., Chen, J., Liu, D., Wu, D., & Xu, Y. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101599
DNA methylation in human disease: From biological mechanisms to clinical applications
Mallik, R., Gupta, P., Gupta, A. K., Chaturvedi, P., Pillai, V., & Muegge, K. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.102635
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
